On February 3, 2020 VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, reported that Prof. Dror Harats, M.D., Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference, being held at the Marriott Marquis Times Square on February 10-11, 2020, in New York City (Press release, VBL Therapeutics, FEB 3, 2020, View Source [SID1234553783]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:
Date: Monday, February 10th
Time: 10:15 AM Eastern Time
Location: Marriott Marquis Times Square
Presentation Room: Wilder (4th Floor)
Webcast: Webcast